Skip to content
ppharmaranks
Menu
Class IIOngoing

Neuroquell & Neuroquell Plus recall

FDA recall D-0629-2025 · initiated Aug 27, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 17, 2025How we research

Atlantic Management Resources Ltd. recalled Neuroquell & Neuroquell Plus in Aug 2025 — an FDA Class II recall (D-0629-2025) because cGMP violations.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

cGMP violations

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # B-02 Batch #: 1087920520 Product # R937 BBE#31-05-21( May 31, 2021) Batch # 1087920920 Product # R937 BBE# 31-05-21 (May 31, 2021)

Quantity recalled: 72 containers

Details

Product
Neuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901 Westboro, MA 01581 USA, NDC 66233712-01
Recalling company
Atlantic Management Resources Ltd.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product was distributed via the internet.
Initiated
Aug 27, 2025
FDA report date
Sep 17, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Neuroquell & Neuroquell Plus recalled?
Atlantic Management Resources Ltd. recalled Neuroquell & Neuroquell Plus in Aug 2025 — an FDA Class II recall (D-0629-2025) because cGMP violations. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Neuroquell & Neuroquell Plus recalled?
Per the FDA enforcement record, the reason for recall D-0629-2025 was: cGMP violations
Is a recalled Neuroquell & Neuroquell Plus dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Neuroquell & Neuroquell Plus are affected?
Distributed: Product was distributed via the internet.. The recall covers these lots — Lot # B-02 Batch #: 1087920520 Product # R937 BBE#31-05-21( May 31, 2021) Batch # 1087920920 Product # R937 BBE# 31-05-21 (May 31, 2021). Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0629-2025.

Source: openFDA Drug Enforcement record D-0629-2025

← All drug recalls